SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 52 filers reported holding SIO GENE THERAPIES INC in Q4 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $756,867 | +46.7% | 1,739,923 | -5.5% | 0.00% | – |
| Q3 2022 | $516,000 | -31.7% | 1,840,707 | -12.3% | 0.00% | – |
| Q2 2022 | $756,000 | -46.2% | 2,098,581 | 0.0% | 0.00% | – |
| Q1 2022 | $1,406,000 | -49.3% | 2,098,581 | -2.4% | 0.00% | – |
| Q4 2021 | $2,773,000 | -37.7% | 2,149,152 | +4.7% | 0.00% | – |
| Q3 2021 | $4,454,000 | -16.3% | 2,052,488 | +5.3% | 0.00% | – |
| Q2 2021 | $5,319,000 | +98.4% | 1,948,262 | +89.7% | 0.00% | – |
| Q1 2021 | $2,681,000 | -12.4% | 1,027,290 | -6.7% | 0.00% | – |
| Q4 2020 | $3,062,000 | – | 1,101,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,186,335 | $8,316,000 | 0.89% |
| Opaleye Management Inc. | 2,000,000 | $5,220,000 | 0.77% |
| Prosight Management, LP | 205,900 | $537,000 | 0.44% |
| Rubric Capital Management LP | 2,500,418 | $6,526,000 | 0.38% |
| Sio Capital Management, LLC | 460,248 | $1,201,000 | 0.24% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,489,000 | $14,326,000 | 0.21% |
| KNOTT DAVID M | 70,000 | $183,000 | 0.08% |
| Insight Advisors, LLC/ PA | 82,700 | $232,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 146,968 | $384,000 | 0.06% |
| Hudson Bay Capital Management LP | 1,600,000 | $4,176,000 | 0.05% |